24 studies found for:    "Erythema multiforme"
Show Display Options
Rank Status Study
1 Completed
Has Results
Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%
Condition: Plaque Psoriasis
Intervention: Drug: Clobex Spray
2 Completed Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.
Conditions: Stevens-Johnson Syndrome;   Toxic Epidermal Necrolysis
Intervention: Drug: Intravenous immunoglobulin
3 Unknown  Corneal Epitheliotropic Factors in Autologous Serum Eye Drops in Nonautoimmune and Stevens-Johnson Syndrome With Dry Eye
Condition: Stevens-Johnson Syndrome
Intervention:
4 Not yet recruiting Topical Infliximab in Autoimmune Eyes With Keratoprosthesis
Conditions: Stevens-Johnson Syndrome;   Toxic Epidermal Necrolysis (Lyell) Syndrome;   Mucous Membrane Pemphigoid
Intervention: Drug: topical infliximab
5 Withdrawn Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)
Condition: Toxic Epidermal Necrolysis
Intervention: Drug: Remicaide (infliximab)
6 Completed Stevens-Johnson Syndrome Antimicrobial
Condition: Stevens-Johnson Syndrome
Intervention:
7 Enrolling by invitation Salivary Gland Transplantation in the Treatment of Dry Eye in Patients With Stevens-Johnson Syndrome.
Conditions: Symblepharon;   Dry Eye;   Ocular Surface Disease;   Transplantation
Intervention: Procedure: Salivary Gland and Labial Mucous Membrane Transplantation
8 Recruiting Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal Necrolysis
Conditions: Toxic Epidermal Necrolysis;   Stevens-Johnson Syndrome
Intervention: Drug: Palifermin
9 Completed Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface Transplantation
Conditions: Pterygium;   Ocular Surface Disease;   Stevens Johnson Syndrome;   Chemical Injury
Intervention: Procedure: Cultivated conjunctival transplantation
10 Recruiting Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis
Conditions: Chemical Injuries;   Unspecified Complication of Corneal Transplant;   Autoimmune Diseases;   Ocular Cicatricial Pemphigoid;   Stevens Johnson Syndrome;   Lupus Erythematosus, Systemic;   Rheumatoid Arthritis;   Other Autoimmune Diseases
Intervention: Drug: Riboflavin
11 Recruiting Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)
Conditions: Stevens-Johnson Syndrome;   Corneal Blindness
Intervention: Drug: Infliximab
12 Completed Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye
Condition: Stevens-Johnson Syndrome
Intervention: Drug: 0.05%cyclosporin eye drop
13 Completed Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
Condition: Head and Neck Cancer
Intervention: Drug: liposomal lurtotecan
14 Recruiting Resolute Integrity US Extended Length Sub-Study(RI-US XL)
Condition: Coronary Artery Disease
Intervention: Device: Resolute Integrity Stent
15 Active, not recruiting An Evaluation of the Commercially Available Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent System
Condition: Coronary Artery Disease
Intervention: Procedure: Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent System (Resolute Integrity Stent)
16 Active, not recruiting
Has Results
RESOLUTE Japan - The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary Stent
Conditions: Arterial Occlusive Diseases;   Myocardial Ischemia;   Cardiovascular Diseases;   Coronary Artery Disease
Intervention: Device: MDT-4107 Drug Eluting Stent
17 Active, not recruiting Evaluation of the Endeavor Resolute Zotarolimus-Eluting Coronary Stent System in a Real-World Patient Population in China
Conditions: Ischemic Heart Disease;   Stenotic Coronary Lesion;   Cardiovascular Diseases;   Arteriosclerosis;   Coronary Artery Disease
Intervention:
18 Active, not recruiting
Has Results
The Medtronic RESOLUTE US Clinical Trial
Condition: Coronary Artery Disease
Intervention: Device: Resolute Zotarolimus-Eluting Coronary Stent
19 Active, not recruiting RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in Asia
Conditions: Ischemic Heart Disease;   Stenotic Coronary Lesion;   Cardiovascular Diseases;   Arteriosclerosis;   Coronary Artery Disease
Intervention: Device: Drug eluting stent treatment
20 Active, not recruiting Resolute Zotarolimus-Eluting Stent Versus the Taxus Liberte Paclitaxel-Eluting Stent for Percutaneous Coronary Intervention in China
Conditions: Ischemic Heart Disease;   Stenotic Coronary Lesion;   Cardiovascular Diseases;   Arteriosclerosis;   Coronary Artery Disease
Interventions: Device: Taxus Liberte Paclitaxel-Eluting Coronary Stent System;   Device: Resolute Zotarolimus-Eluting Coronary Stent System

Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results
Indicates status has not been verified in more than two years